Taken from Osteogenesis imperfecta, Nature Reviews by Joan C. Marini, Antonella Forlino, Hans Peter Bächinger, Nick J. Bishop, Peter H. Byers, Anne De Paepe, Francois Fassier, Nadja Fratzl-Zelman, Kenneth M. Kozloff, Deborah Krakow, Kathleen Montpetit and Oliver Semler [1].
Weis MA, Hudson DM, Kim L, Scott M, Wu JJ, Eyre DR; ''Location of 3-hydroxyproline residues in collagen types I, II, III, and V/XI implies a role in fibril supramolecular assembly.''; J Biol Chem, 2010 PubMedEurope PMCScholia
Marini JC, Forlino A, Bächinger HP, Bishop NJ, Byers PH, Paepe A, Fassier F, Fratzl-Zelman N, Kozloff KM, Krakow D, Montpetit K, Semler O; ''Osteogenesis imperfecta.''; Nat Rev Dis Primers, 2017 PubMedEurope PMCScholia
Morello R, Bertin TK, Chen Y, Hicks J, Tonachini L, Monticone M, Castagnola P, Rauch F, Glorieux FH, Vranka J, Bächinger HP, Pace JM, Schwarze U, Byers PH, Weis M, Fernandes RJ, Eyre DR, Yao Z, Boyce BF, Lee B; ''CRTAP is required for prolyl 3- hydroxylation and mutations cause recessive osteogenesis imperfecta.''; Cell, 2006 PubMedEurope PMCScholia
Forlino A, Cabral WA, Barnes AM, Marini JC; ''New perspectives on osteogenesis imperfecta.''; Nat Rev Endocrinol, 2011 PubMedEurope PMCScholia
Vranka JA, Sakai LY, Bächinger HP; ''Prolyl 3-hydroxylase 1, enzyme characterization and identification of a novel family of enzymes.''; J Biol Chem, 2004 PubMedEurope PMCScholia